UHSHealthcare · Medical Care FacilitiesThe 20 Wall Street analysts covering Universal Health Services, Inc. hold a median 12-month price target of $194 — -1.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 57 of 100 as at 3 Nov 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Universal Health Services, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (98): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Momentum (32): The shares have been drifting down relative to others.
Size (15): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on UHS, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits −1.3% from it.
Of the 20 most recent actions, 2 moved their price target up and 7 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 2 Nov 2026 | Wells Fargo | Maintains | Equal-Weight | $166 → $170 |
| 29 Oct 2026 | Baird | Maintains | Neutral | $166 → $156 |
| 29 Oct 2026 | Guggenheim | Maintains | Buy | $209 → $201 |
| 18 Sept 2026 | Leerink Partners | Maintains | Outperform | — |
| 18 Sept 2026 | Leerink Partners | Maintains | Outperform | $198 → $205 |
| 20 Aug 2026 | RBC Capital | Reiterates | Sector Perform | $183 |
| 20 Aug 2026 | RBC Capital | Reiterates | Sector Perform | — |
| 3 Aug 2026 | RBC Capital | Maintains | Sector Perform | — |
| 3 Aug 2026 | RBC Capital | Maintains | Sector Perform | $190 → $183 |
| 30 July 2026 | Goldman Sachs | Maintains | Neutral | — |
| 30 July 2026 | Goldman Sachs | Maintains | Neutral | $242 → $190 |
| 29 July 2026 | Baird | Maintains | Neutral | $204 → $166 |
| 29 July 2026 | Baird | Maintains | Neutral | — |
| 29 July 2026 | Cantor Fitzgerald | Reiterates | Neutral | $194 |
| 29 July 2026 | Cantor Fitzgerald | Reiterates | Neutral | — |
| 29 July 2026 | Guggenheim | Maintains | Buy | — |
| 29 July 2026 | Guggenheim | Maintains | Buy | $195 → $189 |
| 29 July 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 29 July 2026 | Morgan Stanley | Maintains | Equal-Weight | $212 → $191 |
| 28 July 2026 | Barclays | Maintains | Equal-Weight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
UHS appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, Universal Health Services, Inc. returned −11.9% against +12.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 63% of US stocks
Cheaper than 78% of US stocks
Cheaper than 55% of US stocks
Cheaper than 50% of US stocks
Higher than 41% of US stocks
Higher than 22% of US stocks
Higher than 96% of US stocks
Higher than 63% of US stocks
Higher than 66% of US stocks
Higher than 81% of US stocks
Higher than 87% of US stocks
Higher than 65% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Universal Health Services, Inc. has a market value of $10.6B and an enterprise value of $16.8B.
Revenue in the twelve months to 30 June 2026: $18.1B. The latest quarter grew 5.3% year on year.
Net income over the same four quarters: $1.6B, a 8.6% net margin.
Diluted earnings per share, trailing twelve months: $24.55.
Free cash flow in the twelve months to 30 June 2026: $810.7M.
Universal Health Services, Inc. spent $1.1B on share buybacks and $49.6M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 7.3×; forward P/E: 7.5× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.45%, paying out 3% of earnings.
Universal Health Services, Inc. employs 102,000 people — $178K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Universal Health Services, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Healthcare stocks, including hospital groups and companies operating in state Medicaid and Affordable Care Act markets, jumped after the midterm results.
Why it matters — UHS watchers may note the reported rise in hospital-group shares alongside gains in other healthcare stocks.
The excerpt says the Democratic victory in the midterm elections could benefit the nation’s largest hospitals. The headline contrasts a rally in hospital stocks with drugmakers facing scrutiny.
Why it matters — UHS watchers may note the item’s favorable framing of potential effects on large hospitals.
Universal Health Services, Inc. is scheduled to present at the UBS Global Healthcare Conference on November 10, 2026, at 9:30 a.m.
Why it matters — UHS watchers may note the scheduled company presentation at the healthcare conference.
Universal Health Services reported third-quarter adjusted earnings per share of $5.22, down 8% year over year. The company cited favorable acute-care demand, improving behavioral-health volumes and moderating labor pressures, but said results were below internal expectations excluding certain items.
Why it matters — UHS watchers may note the earnings decline and the company’s mixed operating trends and below-expectations results.
Universal Health Services reported Q3 earnings that fell 8.3% despite revenue growth and higher patient volumes. Rising costs and Acute Care pricing pressure offset the volume gains, and earnings missed estimates.
Why it matters — The results highlight how rising costs and pricing pressure affected UHS earnings despite increased patient volumes.
The 20 Wall Street analysts covering Universal Health Services, Inc. have a median 12-month price target of $194, with estimates ranging from $156 to $250. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 20 analysts covering Universal Health Services, Inc., 6 rate it a Buy, 13 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Universal Health Services, Inc. 57 out of 100 across roughly 4,600 US stocks as at 3 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 3 Nov 2026, Universal Health Services, Inc. ranks 57 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (98 of 100).
No one can know that. What the data says: the median 12-month target from 20 analysts implies -1.3% from the last close, and Ticker Nerd's factor model ranks Universal Health Services, Inc. 57 out of 100 as at 3 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Universal Health Services, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for UHS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $156 to $250 over the next 12 months.
Universal Health Services, Inc. returned -11.9% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
Universal Health Services Inc. Class B Common Stock represents an equity interest in Universal Health Services, a healthcare services company that owns and operates acute care hospitals, behavioral health facilities, surgical hospitals, ambulatory surgery centers, and related outpatient care centers.
The most recent item we track (Barrons, 4 Nov 2026): "Healthcare Stocks Bounce on Midterm Results. A Bull Market Case Is Developing.". Healthcare stocks, including hospital groups and companies operating in state Medicaid and Affordable Care Act markets, jumped after the midterm results.
Universal Health Services Inc. Class B Common Stock represents an equity interest in Universal Health Services, a healthcare services company that owns and operates acute care hospitals, behavioral health facilities, surgical hospitals, ambulatory surgery centers, and related outpatient care centers. Universal Health Services serves patients through a broad network of medical and behavioral health services, including emergency care, specialty medicine, diagnostic imaging, surgery, rehabilitation, psychiatric treatment, and addiction-focused programs. The company’s operations are organized around hospital-based and behavioral health segments, supported by centralized management and administrative services that help coordinate clinical delivery, purchasing, finance, and facility operations. Universal Health Services plays a significant role in the U.S. healthcare market by providing essential inpatient and outpatient services across multiple care settings and patient needs.
CEO Mr. Marc D. Miller · 102,000 employees · United States · https://uhs.com
